We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current HLS market cap is 105.53M. The company's latest EPS is USD -0.8609 and P/E is -3.79.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 54.16M | 56.62M | 60.01M | 61.47M | 63.61M |
| Operating Income | -4.63M | -11.58M | -6.28M | -18.68M | -16.57M |
| Net Income | -19.55M | -15.33M | -13.12M | -23.6M | -27.53M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 319.67M | 303.91M | 275.91M | 241.65M | 209.06M |
| Total Liabilities | 141.47M | 134.66M | 115.17M | 116.33M | 111.36M |
| Total Equity | 178.2M | 169.25M | 160.74M | 125.32M | 97.7M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 26.41M | 9.34M | 16.43M | 16.94M | 15.79M |
| Investing | -15.36M | -44.68M | -4.51M | -10.15M | -189k |
| Financing | 23.95M | 9.56M | -11.4M | -6.86M | -14.64M |
| Market Cap | 105.53M |
| Price to Earnings Ratio | -3.79 |
| Price to Sales Ratio | 1.64 |
| Price to Cash Ratio | 4.75 |
| Price to Book Ratio | 1.07 |
| Dividend Yield | - |
| Shares Outstanding | 31.98M |
| Average Volume (1 week) | 43.78k |
| Average Volume (1 Month) | 51.38k |
| 52 Week Change | -11.53% |
| 52 Week High | 5.48 |
| 52 Week Low | 3.01 |
| Spread (Intraday) | 0.12 (3.53%) |
| Company Name | HLS Therapeutics Inc |
| Address |
10 carlson court, suite 701 toronto, ontario M9W, 6L2 |
| Website | https://www.hlstherapeutics.com |
| Industry | motor vehicle part,accessory (3714) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
